Related Experiment Video
Updated: Nov 9, 2025

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Oral immunotherapy in food allergies: A practical update for pediatricians
M Sabouraud1, P Biermé2, S-A Andre-Gomez2
1University of Lyon 1 Claude-Bernard, Villeurbanne, France; Pediatric Pulmonology and Allergology Department, Pediatric Cystic Fibrosis Center, hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.
Insights
Food oral immunotherapy (OIT) is a promising treatment for severe food allergies in children, accelerating tolerance to milk and egg. While effective for desensitization, OIT has frequent side effects requiring careful management and ongoing research for improved safety.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Therapeutics
- Immunotherapy
Background:
- Food allergies (FAs) significantly impact children's health, necessitating effective treatments.
- Food oral immunotherapy (OIT) is emerging as a key strategy for managing severe FAs, particularly cow's milk and hen's egg allergies.
- Pediatricians increasingly manage children undergoing FA-OIT, requiring knowledge of its efficacy, safety, and management.
Purpose of the Study:
- To review the efficacy and safety of food oral immunotherapy (OIT) in pediatric patients.
- To discuss the mechanisms, phases, and outcomes of FA-OIT, including desensitization and sustained unresponsiveness.
- To highlight the role of pediatricians in managing FA-OIT, including patient education, reaction management, and referral.
Main Methods:
- Review of existing literature on food oral immunotherapy (OIT) for pediatric food allergies.
- Analysis of OIT protocols, including up-dosing and maintenance phases.
- Examination of reported side effects, long-term outcomes, and management strategies.
Main Results:
- FA-OIT demonstrates efficacy in achieving desensitization and, in some cases, sustained unresponsiveness to allergens like cow's milk and hen's egg.
- Frequent side effects, such as oral syndromes and systemic reactions, occur primarily during the up-dosing phase, often leading to treatment discontinuation.
- Long-term side effects like eosinophilic esophagitis are possible, necessitating vigilant monitoring.
Conclusions:
- FA-OIT is a valuable treatment for pediatric food allergies, but its safety profile requires careful consideration and patient education.
- Effective management of side effects and ongoing research into alternative administration routes and adjuvant therapies are crucial for improving the risk-benefit ratio of OIT.
- Pediatricians play a vital role in supporting patients and families through FA-OIT, ensuring adherence and timely intervention for adverse events.
Abstract:
Food oral immunotherapy (OIT) is a promising treatment for persistent and severe food allergies (FAs) in children, but also for accelerating tolerance to cow's milk and cooked egg in young children. In the near future, pediatricians will increasingly encounter severely allergic children undergoing FA-OIT. FA-OIT consists in daily ingestion of increasing doses of the allergen during the up-dosing phase, and ingestion of a constant dose during the maintenance phase. The global aim is to increase the reactive threshold of allergic patients, and finally enable them to ingest a target quantity of allergen without any reaction throughout the treatment (desensitization). Many studies showed the efficacy of FA-OIT in desensitization, and some of them in sustained unresponsiveness. This corresponds to tolerance after FA-OIT discontinuation, especially for cow's milk and hen's egg allergy. However, there is an ongoing debate about the safety of the treatment. Side effects are frequent, notably aversion to the allergen and oral syndromes as well as systemic allergic symptoms. These reactions occur mainly during the up-dosing phase and become less frequent with time, but they are common causes of FA-OIT discontinuation. Patients and their families must be trained to manage these reactions at home. Long-term side effects can also occur, such as eosinophilic esophagitis. Pediatricians play an important role in maintaining patient motivation; they also provide knowledge on possible allergic reactions and the reactogenic cofactors (mainly fever and viral infection, anti-inflammatory intake, physical activity), and refer the patient to the relevant specialists in the case of long-term care. Other routes of administration for food immunotherapy (epicutaneous and sublingual) and different adjuvant treatments (probiotics, anti-IgE molecule) are currently under study. This will allow us to improve the efficacy of immunotherapy and reduce the risk of any side effects, in order to provide a more favorable risk-benefit ratio.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions
Allergic Drug Reactions
Taste Buds and Receptors
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

